Physician

Adam Louis Peyton, DO

According to 2025 Medicare claims, Adam Peyton, DO (NPI: 1558565598) practices gastroenterology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Lehigh, PA. This provider's primary affiliated billing organization is LEHIGH VALLEY PHYSICIAN GROUP (NPI: 1083339741; TIN: 232700908) and primary practice location at 18104-2309. Peyton is affiliated with the Lehigh Valley Health Network Accountable Care Organization, LLC (ACO ID: A2735), participating under the MSSP model.

Peyton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 590 traditional Medicare patients, billed 27,155 HCPCS/CPT codes, and received $534,678 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,596 prescription claims across 286 beneficiaries totaling $1,682,198 in drug costs, led by Ocaliva (Obeticholic Acid). 2023 DME data shows 12 claims. Open Payments data shows 136 records totaling $138,173. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $62,497 to $534,678. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $6,951,232 to $1,682,198. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$267K$535K2015 Medicare payment: $62,497 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $151,094 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $163,950 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $124,849 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $115,884 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $104,127 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $151,765 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $284,624 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $248,838 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $534,678 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015441756$62,497
20167051,961$151,094
20177302,715$163,950
20186632,022$124,849
20195422,959$115,884
20204602,370$104,127
20214834,991$151,765
202250913,932$284,624
202352310,091$248,838
202459027,155$534,678

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.5M$7.0M2015 Drug cost: $6,951,232 (USD; Tot_Drug_Cst)2016 Drug cost: $4,324,957 (USD; Tot_Drug_Cst)2017 Drug cost: $3,138,624 (USD; Tot_Drug_Cst)2018 Drug cost: $1,917,444 (USD; Tot_Drug_Cst)2019 Drug cost: $1,618,263 (USD; Tot_Drug_Cst)2020 Drug cost: $1,295,007 (USD; Tot_Drug_Cst)2021 Drug cost: $1,267,070 (USD; Tot_Drug_Cst)2022 Drug cost: $1,038,457 (USD; Tot_Drug_Cst)2023 Drug cost: $1,112,281 (USD; Tot_Drug_Cst)2024 Drug cost: $1,682,198 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015142740$6,951,232
2016169736$4,324,957
2017180999$3,138,624
2018148985$1,917,444
20191851,226$1,618,263
20201551,142$1,295,007
20211801,251$1,267,070
20222001,316$1,038,457
20232261,323$1,112,281
20242861,596$1,682,198

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.1K$2.1K2015 Medicare payment: $2,139 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $265 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R36$2,139
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R12$265
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes103107$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more99121$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more126149$61
91200Measurement of liver stiffness7979$21
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's123142$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OcalivaObeticholic Acid471,590$496,025
XifaxanRifaximin1123,464$361,630
RezdiffraResmetirom491,470$196,199
LivdelziSeladelpar Lysine11330$142,075
VemlidyTenofovir Alafenamide251,050$47,956

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.131$128,993Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.5$9,180Bausch Health US, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Louis Peyton, DO?

Tedicare shows public-source Medicare data for Adam Louis Peyton, DO (NPI 1558565598), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Louis Peyton, DO have ACO affiliation data?

Adam Louis Peyton, DO is shown with ACO affiliation data for Lehigh Valley Health Network Accountable Care Organization, LLC (MSSP, ACO ID A2735).

What billing organization is linked to Adam Louis Peyton, DO?

Adam Louis Peyton, DO is linked to LEHIGH VALLEY PHYSICIAN GROUP (billing NPI 1083339741) in the available physician profile data.

Does Adam Louis Peyton, DO have Open Payments data?

Adam Louis Peyton, DO has 136 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.